Spots Global Cancer Trial Database for cell cycle
Every month we try and update this database with for cell cycle cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | NCT00055380 | Cancer | Oral cytobrushi... | - | National Institutes of Health Clinical Center (CC) | |
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer | NCT02797964 | Advanced Solid ... | SRA737 | 18 Years - | Sierra Oncology LLC - a GSK company | |
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma | NCT04941274 | Kaposi Sarcoma | Abemaciclib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | NCT00055380 | Cancer | Oral cytobrushi... | - | National Institutes of Health Clinical Center (CC) | |
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck | NCT00011778 | Squamous Cell C... | bortezomib radiation thera... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer | NCT02797964 | Advanced Solid ... | SRA737 | 18 Years - | Sierra Oncology LLC - a GSK company | |
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma | NCT04941274 | Kaposi Sarcoma | Abemaciclib | 18 Years - | National Institutes of Health Clinical Center (CC) |